We are live on
!
Find out more
AC
Ascend Capital Portfolio holdings
AUM
$1.99B
1-Year Est. Return
10.36%
This Fund
S&P 500
This Quarter
Est. Return
+5.95%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.65B
AUM Growth
+$502M
(+23%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
4.8%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
215
New
70
Increased
41
Reduced
38
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Host Hotels & Resorts
HST
|
+$61.6M |
| 2 |
Puma Biotechnology
PBYI
|
+$61.1M |
| 3 |
Prudential Financial
PRU
|
+$61M |
| 4 |
Viatris
VTRS
|
+$49.3M |
| 5 |
ANDV
Andeavor
ANDV
|
+$49.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$53.9M |
| 2 |
Tapestry
TPR
|
+$32.5M |
| 3 |
Pfizer
PFE
|
+$32.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$30.7M |
| 5 |
Kraft Heinz
KHC
|
+$30.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.41% |
| 2 | Healthcare | 14.35% |
| 3 | Technology | 11.67% |
| 4 | Energy | 8.22% |
| 5 | Materials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANW
101
DELISTED
Aegean Marine Petroleum Network
ANW
| $4.5M | 0.17% |
908,646
+663,458
| +271% | +$3.28M |
|
|
BOLD
102
DELISTED
Audentes Therapeutics, Inc
BOLD
| $4.25M | 0.16% |
+151,786
| New | +$3.3M |
|
103
Boyd Gaming
BYD
$6.75B
| $3.95M | 0.15% |
151,576
-50,094
| -25% | -$1.3M |
|
|
FOLD
104
DELISTED
Amicus Therapeutics
FOLD
| $3.81M | 0.14% |
+252,522
| New | +$3.34M |
|
|
NXEO
105
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $3.81M | 0.14% |
521,593
+361,316
| +225% | +$2.77M |
|
106
Celldex Therapeutics
CLDX
$2.94B
| $3.63M | 0.14% |
+84,722
| New | +$3.18M |
|
107
Virtus Investment Partners
VRTS
$1.12B
| $3.63M | 0.14% |
31,290
-3,995
| -11% | -$446K |
|
108
Molina Healthcare
MOH
$10.4B
| $3.48M | 0.13% |
+50,630
| New | +$3.3M |
|
109
SiteOne Landscape Supply
SITE
$4.16B
| $3.48M | 0.13% |
59,887
-205,270
| -77% | -$10.7M |
|
110
Hubbell
HUBB
$24.4B
| $3.35M | 0.13% |
+28,871
| New | +$3.31M |
|
|
SAFE
111
DELISTED
Safehold Inc.
SAFE
| $3.34M | 0.13% |
178,928
-578
| -0.3% | -$11.1K |
|
112
Madrigal Pharmaceuticals
MDGL
$12.6B
| $3.31M | 0.12% |
+73,515
| New | +$1.38M |
|
113
Neurogene
NGNE
$672M
| $3.04M | 0.11% |
10,725
+9
| +0.1% | +$2.58K |
|
114
Bunge Global
BG
$20.9B
| $3.04M | 0.11% |
+43,819
| New | +$3.32M |
|
115
iRhythm Holdings
IRTC
$4.02B
| $3M | 0.11% |
57,809
-244,891
| -81% | -$11.1M |
|
116
First Horizon
FHN
$12.2B
| $2.91M | 0.11% |
+151,891
| New | +$2.66M |
|
|
ETFC
117
DELISTED
E*Trade Financial Corporation
ETFC
| $2.88M | 0.11% |
66,001
-13,999
| -17% | -$569K |
|
|
JNCE
118
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.81M | 0.11% |
+180,629
| New | +$2.55M |
|
119
Dollar Tree
DLTR
$24.8B
| $2.77M | 0.1% |
+31,862
| New | +$2.43M |
|
120
Zimmer Biomet
ZBH
$18.8B
| $2.77M | 0.1% |
24,332
-87,916
| -78% | -$10.1M |
|
|
CQH
121
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $2.58M | 0.1% |
102,733
-43,278
| -30% | -$1.11M |
|
122
Roper Technologies
ROP
$40.4B
| $2.51M | 0.09% |
+10,315
| New | +$2.42M |
|
|
ASRT
123
DELISTED
Assertio
ASRT
| $2.51M | 0.09% |
+7,220
| New | +$3.4M |
|
124
Aptiv
APTV
$12.3B
| $2.46M | 0.09% |
+25,000
| New | +$2.36M |
|
|
125
Pfizer
PFE
$143B
| $2.29M | 0.09% |
67,566
-1,006,132
| -94% | -$32.3M |
|
Similar funds
MWAC
TP
PC
RW
TBC
BWCA
AC
GCM
Ascend Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Ascend Capital held 215 positions worth $2.65B, up 23% from $2.15B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ascend Capital deployed $127M of net new capital in Q3 2017, opening 70 new positions and adding to 41 existing holdings. Its largest new stake was Host Hotels & Resorts: 3,386,281 shares worth $62.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was MetLife, an estimated $53.9M trimmed.
- Ascend Capital's largest Q3 2017 buy was Host Hotels & Resorts: 3,386,281 shares worth $62.6M.
- Ascend Capital added most to Puma Biotechnology in Q3 2017, an estimated $61.1M increase.
- Ascend Capital's biggest Q3 2017 reduction was MetLife, cutting an estimated $53.9M.
- Ascend Capital fully exited Tapestry in Q3 2017, selling an estimated $32.5M.
- Ascend Capital's ten largest holdings make up 27% of its $2.65B portfolio in Q3 2017.
- Ascend Capital opened 70 new positions and closed 54 in Q3 2017.
- Ascend Capital's portfolio value rose 23% quarter-over-quarter to $2.65B.
Based on Ascend Capital's 13F filing for Q3 2017, filed 13 Nov 2017.